JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Hereby, MSCs in combination with eltrombopag triggered profound synergetic pro-differentiation effects through the phosphorylation of JAK2, STAT3, and p38 MAPK in CML cells.